{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:46:26Z","timestamp":1783129586892,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/dmd.123.001326","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T20:50:15Z","timestamp":1684183815000},"page":"1046-1052","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6218-4023","authenticated-orcid":false,"given":"Julia A.","family":"Schulz Pauly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3852-2280","authenticated-orcid":false,"given":"Colin J.","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Cory","family":"Kalvass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.123.001326_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40262-017-0584-7","article-title":"Pharmacokinetics and pharmacodynamics of temocillin","volume":"57","author":"Alexandre","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.123.001326_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/00498250701658296","article-title":"Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake","volume":"37","author":"Baker","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.123.001326_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cpt.802","article-title":"The universally unrecognized assumption in predicting drug clearance and organ extraction ratio","volume":"103","author":"Benet","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001326_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12248-020-00501-9","article-title":"Investigating the theoretical basis for in vitro-in vivo extrapolation (IVIVE) in predicting drug metabolic clearance and proposing future experimental pathways","volume":"22","author":"Benet","year":"2020","journal-title":"AAPS J"},{"key":"10.1124\/dmd.123.001326_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cpt.2482","article-title":"Can in vitro-in vivo extrapolation be successful? recognizing the incorrect clearance assumptions","volume":"111","author":"Benet","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001326_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12248-021-00591-z","article-title":"There is only one valid definition of clearance: critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions","volume":"23","author":"Benet","year":"2021","journal-title":"AAPS J"},{"key":"10.1124\/dmd.123.001326_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/clpt.1980.192","article-title":"Valproic acid dosage and plasma protein binding and clearance","volume":"28","author":"Bowdle","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001326_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01621459.1976.10480949","article-title":"Science and statistics","volume":"71","author":"Box","year":"1976","journal-title":"J Am Stat Assoc"},{"key":"10.1124\/dmd.123.001326_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02879","article-title":"An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions","volume":"5","author":"Bteich","year":"2019","journal-title":"Heliyon"},{"key":"10.1124\/dmd.123.001326_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/bdd.1784","article-title":"Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions","volume":"33","author":"Camenisch","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.123.001326_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01071000","article-title":"Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver","volume":"20","author":"D\u00edaz-Garc\u00eda","year":"1992","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejps.2018.09.021","article-title":"Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake","volume":"125","author":"Fujino","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.123.001326_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01062965","article-title":"Disposition of prednisone and prednisolone in the perfused rabbit liver: modeling hepatic metabolic processes","volume":"19","author":"Hale","year":"1991","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111855","article-title":"Precisely adjusting the hepatic clearance of highly extracted drugs using the modified well-stirred model","volume":"141","author":"Hsu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/dmd.123.001326_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/oxfordjournals.jbchem.a135113","article-title":"The role of albumin in the hepatic transport of bilirubin: studies in mutant analbuminemic rats","volume":"97","author":"Inoue","year":"1985","journal-title":"J Biochem"},{"key":"10.1124\/dmd.123.001326_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11095-004-9015-1","article-title":"Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches","volume":"22","author":"Ito","year":"2005","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001326_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3565(25)21990-5","article-title":"Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding","volume":"229","author":"Jones","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.123.001326_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1208\/s12248-021-00656-z","article-title":"Assessment of the Kochak-Benet equation for hepatic clearance for the parallel-tube model: relevance of classic clearance concepts in PK and PBPK","volume":"24","author":"Jusko","year":"2021","journal-title":"AAPS J"},{"key":"10.1124\/dmd.123.001326_bib20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/dmd.117.078915","article-title":"Mathematical and experimental validation of flux dialysis method: an improved approach to measure unbound fraction for compounds with high protein binding and other challenging properties","volume":"46","author":"Kalvass","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib21","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.xphs.2020.01.024","article-title":"Critical analysis of hepatic clearance based on an advection mass transfer model and mass balance","volume":"109","author":"Kochak","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.123.001326_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM197602052940605","article-title":"Binding of drugs to serum albumin (first of two parts)","volume":"294","author":"Koch-Weser","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.123.001326_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1124\/dmd.122.001060","article-title":"Process and system clearances in pharmacokinetic models: our basic clearance concepts are correct","volume":"51","author":"Korzekwa","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib24","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s00204-018-2224-x","article-title":"The impact of desorption kinetics from albumin on hepatic extraction efficiency and hepatic clearance: a model study","volume":"92","author":"Krause","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.123.001326_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/dmd.120.000064","article-title":"Comparison of In vitro to in vivo extrapolation approaches for predicting transporter-mediated hepatic uptake clearance using suspended rat hepatocytes","volume":"48","author":"Li","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib26","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1021\/bi201284u","article-title":"The original Michaelis constant: translation of the 1913 Michaelis-Menten paper","volume":"50","author":"Michaelis","year":"2011","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.123.001326_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2018.07.004","article-title":"Concentration-dependent plasma protein binding: expect the unexpected","volume":"122","author":"Nation","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.123.001326_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance","volume":"5","author":"Pang","year":"1977","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF01059689","article-title":"Hepatic clearance of drugs. II. Experimental evidence for acceptance of the \u201cwell-stirred\u201d model over the \u201cparallel tube\u201d model using lidocaine in the perfused rat liver in situ preparation","volume":"5","author":"Pang","year":"1977","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/jps.22792","article-title":"In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods","volume":"101","author":"Poulin","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.123.001326_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01106706","article-title":"A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations","volume":"14","author":"Roberts","year":"1986","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01106707","article-title":"A dispersion model of hepatic elimination: 2. Steady-state considerations\u2014influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity","volume":"14","author":"Roberts","year":"1986","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF01059626","article-title":"Clearance concepts in pharmacokinetics","volume":"1","author":"Rowland","year":"1973","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01059274","article-title":"Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation","volume":"12","author":"Rowland","year":"1984","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.123.001326_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cpt.921","article-title":"Commentary on \u201cThe Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio.\u201d","volume":"103","author":"Rowland","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001326_bib36","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/cpt.2525","article-title":"Hepatic clearance models and IVIVE predictions","volume":"111","author":"Rowland","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.123.001326_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.121.000637","article-title":"In defense of current concepts and applications of clearance in drug development and therapeutics","volume":"50","author":"Rowland","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/03602532.2023.2195133","article-title":"Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review","author":"Schulz","year":"2023","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.123.001326_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-018-2551-x","article-title":"Pharmacokinetic and pharmacodynamic considerations for drugs binding to alpha-1-acid glycoprotein","volume":"36","author":"Smith","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.123.001326_bib40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/dmd.120.090530","article-title":"Are there any experimental perfusion data that preferentially support the dispersion and parallel tube models over the well-stirred model of organ elimination?","volume":"48","author":"Sodhi","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2125.2006.02827.x","article-title":"Protein binding of cefazolin is saturable in vivo both between and within patients","volume":"63","author":"Vella-Brincat","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.123.001326_bib42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1124\/dmd.119.088872","article-title":"Protein binding and hepatic clearance: re-examining the discrimination between models of hepatic clearance with diazepam in the isolated perfused rat liver preparation","volume":"47","author":"Wang","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib43","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1073\/pnas.91.20.9417","article-title":"Analbuminemia: three cases resulting from different point mutations in the albumin gene","volume":"91","author":"Watkins","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.123.001326_bib44","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1073\/pnas.82.5.1563","article-title":"Dissociation from albumin: a potentially rate-limiting step in the clearance of substances by the liver","volume":"82","author":"Weisiger","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.123.001326_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/03602532.2021.1922435","article-title":"Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data","volume":"53","author":"Yadav","year":"2021","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.123.001326_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/dmd.106.013359","article-title":"Misuse of the well-stirred model of hepatic drug clearance","volume":"35","author":"Yang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.123.001326_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-199312000-00003","article-title":"Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner","volume":"3","author":"Yasumori","year":"1993","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.123.001326_bib48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1074\/jbc.270.3.1074","article-title":"Kinetics of bilirubin transfer between serum albumin and membrane vesicles. Insight into the mechanism of organic anion delivery to the hepatocyte plasma membrane","volume":"270","author":"Zucker","year":"1995","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.123.001326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:03:50Z","timestamp":1739955830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624010298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0090955624010298"],"URL":"https:\/\/doi.org\/10.1124\/dmd.123.001326","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assumptions Underlying Hepatic Clearance Models: Recognizing the Influence of Saturable Protein Binding on Driving Force Concentration and Discrimination Between Models of Hepatic Clearance","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.123.001326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}